News & Noteworthy

New Cloud-based DSCSA Solution Available: Customers now can receive and access all required transaction data from BDI Pharma via electronic portal.  Read More

Bayer's KOVALTRY® is now approved: FDA Approves Bayer's KOVALTRY® Antihemophilic Factor (Recombinant) for the Treatment of Children and Adults with Hemophilia A.  Read More

BDI Pharma, Inc. Chosen as Authorized Distributor for Coagadex®, the first and only FDA-approved treatment for hereditary factor X deficiency. Now in stock and ready to ship! Read More


Programs and Subsidiary Companies


Browse our entire product portfolio and feel free to use the new order inquiry form to receive more information about any of the products that we carry.

Quality Customer Service

BDI Representatives are on-call for your emergency and after-hours needs. Call 1-800-948-9834 for more information or to place an order today.

Contact Us